Arkolith/Insider Trading/PRVB/Form 4

Palmer Ashleigh

Director and CEO, DirectorProvention Bio, Inc. (PRVB) · full profile →Form 4 · filed Jan 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$248K
Net Open-Market Flow
-$248K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 18, 2023Sell(S)24K$10.27$248K2.6M
Jan 18, 2023Option exercise(M)24K$2.50$60K2.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 18, 2023Option exercise(M)24K—$0518K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-002086) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML